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PURPOSE. To determine the molecular basis of lesion development in a murine model of
spontaneous retinal vascularization, rnv3 (retinal vascularization 3, aka JR5558).
METHODS. Disease progression of rnv3 was examined in longitudinal studies by clinical
evaluation, electroretinography (ERG) and light microscopy analyses. The chromosomal
position for the recessive rnv3 mutation was determined by DNA pooling and genome-wide
linkage analysis. The causative mutation was discovered by comparison of whole exome
sequences of rnv3 mutant and wild-type (WT) controls. In order to confirm the causative
mutation, transcription activator-like effector nuclease (TALEN)-mediated oligonucleotide
directed repair (ODR) was utilized to correct the mutant allele. Phenotypic correction was
assessed by fundus imaging and optical coherence tomography of live mice.
RESULTS. rnv3 exhibits early-onset, multifocal depigmented retinal lesions observable by
fundus examination starting at 18 days of age. The retinal lesions are associated with
fluorescein leakage around 25 days of age, with peak leakage at about 4 weeks of age. ERG
responses deteriorate as rnv3 mutants age, concomitant with progressive photoreceptor
disruption and loss that is observable by histology. Genetic analysis localized rnv3 to mouse
chromosome (Chr) 1. By high throughput sequencing of a whole exome capture library of a
rnv3/rnv3 mutant and subsequent sequence analysis, a single base deletion (del) in the Crb1
[crumbs family member 1] gene, which was previously reported to cause retinal
degeneration 8, was identified. The TALEN-mediated ODR rescued the posterior segment
vascularization phenotype; heterozygous Crb1rd8þem1Boc/Crb1rd8 and homozygous
Crb1rd8þem1Boc/Crb1rd8þem1Boc mice showed a normal retinal phenotype. Additionally, six
novel disruptions of Crb1 that were generated through aberrant non-homologous end joining
induced by TALEN exhibited variable levels of vascularization, suggesting allelic effects.
CONCLUSIONS. The rnv3 model and the models of six novel disruptions of Crb1 are all reliable,
novel mouse models for the study of both early and late events associated with posterior
segment vascularization and can also be used to test the effects of pharmacological targets for
treating human ocular vascular disorders. Further study of these models may provide a greater
understanding about how different Crb1 alleles result in aberrant angiogenesis.
Keywords: retinal angiogenesis, retinal vascularization (RNV), spontaneous mutation
Aberrant ocular blood vessel formation can lead to seriouscomplications, causing significant vision impairment and
blindness.1 Abnormal vessels are a prominent feature of eye
diseases such as diabetic retinopathy, age-related macular
degeneration, proliferative retinopathies, and corneal neovas-
cularization, as well as other diseases, such as cancers,
cardiovascular diseases, and neurodegenerative diseases.2–4
Development of reproducible and reliable animal models to
study these vascular diseases has advanced our understanding
of both the normal development and the pathophysiology of
abnormal ocular blood vessel growth.5–8 For example, we
discovered the first retinal vascularization (RNV) phenotype in
Vldlr-targeted null mutant mice and characterized this strain as
a reproducible model of subretinal vascularization and choroi-
dal anastomosis.5 This model, made available through the JAX
Eye Mutant Resource, has enabled numerous studies investi-
gating the potential underlying mechanisms and treatments for
wet AMD, RAP, and macular telangiectasia.9–14 The second
reproducible model of retinal vascularization was discovered in
the figure eight (fgt) model, where a mutation of the adaptor
protein complex AP-1, gamma 1 subunit (Ap1g1) gene6 was
identified. Ap1g1fgt mutant mice develop early vascular lesions
in the retina and provide a reliable animal model for studying
factors that initiate retinal angiogenesis, subretinal vasculariza-
tion, and choroidal vascular anastomosis formation.6 The third
retinal vascular lesion model was identified in a B6;129 mixed
background strain, which we named retinal vascularization 3
(rnv3, aka JR55587 or Nrv28).
Determining the molecular basis for the vascular lesions
provides useful information about the cell types involved and a
better understanding of the nature of the disease and potential
interacting factors. Here we report by genetic mapping and
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whole-exome sequence mutational analysis that the homozy-
gous Crb1rd8, allele is necessary for the retinal vascular disease
phenotype in rnv3 mice. We confirmed the disease-causing
mutation by correction of the mutant Crb1rd8 allele via TALEN-
mediated ODR.
MATERIALS AND METHODS
Mice Husbandry
The mice in this study were bred and maintained in
standardized conditions of the production and research animal
facilities at The Jackson Laboratory (JAX). They were provided
with a NIH31 6% fat chow diet and acidified water, in a
pathogen-free vivarium environment with a 14-hour light/10-
hour dark cycle. All experiments were approved by the
Institutional Animal Care and Use Committee and conducted
in accordance with the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research.
Origins of the Mouse Strains Utilized
The rnv3 mutant was discovered in the mouse stock B6;129-
Crhr1tm1Klee/J (Stock No: 004454), which exhibited fundus
retinal depigmentation spots. The depigmented spots corre-
sponded to areas in which abnormal vascularization was
observed by histology. To test if the retinal vascularization was
due to a heritable mutation, affected mice from this strain were
mated to C57BL/6J mice with normal retinas. The resulting F1
progeny, which did not exhibit ocular abnormalities, were
intercrossed to generate F2 offspring. A total of 46 F2 mice
were examined by indirect ophthalmoscopy for the depigmen-
tation spots and also genotyped for Crhr1tm1Klee. The
depigmentation phenotype did not cosegregate with the
Crhr1tm1Klee targeted allele, indicating that the phenotype
was caused by a new spontaneous mutation, which was named
rnv3, and not by the Crhr1tm1Klee targeted mutation. A male
mouse wild-type (WT) for the Crhr1tm1Klee targeted mutation
was selected to backcross to C57BL/6J for four additional
generations to develop a new strain, B6.Cg-Crb1rd8Jak3m1J/
Boc (stock #: 005558 or JR5558), which carried the rnv3
mutation (same as Crb1rd8) as well as the Jak3m1J mutation
(Supplementary Fig. S1). It should be noted that both
mutations were detected by high-throughput sequencing of
an exome capture library of an rnv3 mutant. To test if the
Jak3m1J mutation contributed to the rnv3 phenotype, the
rnv3 mice were mated to C57BL/6J to produce F1 progeny,
which were subsequently intercrossed. We genotyped 35 F2
mice for both the Crb1rd8 and Jak3m1J mutations. The mice
homozygous Crb1rd8 but wild-type (WT) for Jak3m1J were
selected to develop a new strain, B6.Cg-Crb1rd8Jak3þ/Boc
(stock #: 031586). Mice homozygous for the Jak3m1J mutation
but wild-type for Crb1rd8 were selected to develop another
new strain, B6.Cg-Crb1þJak3m1J/Boc (stock#: 031587) (Sup-
plementary Fig. S2). Finally, in the TALEN rescue experiment in
which we were correcting the Crb1rd8 mutation, seven
additional strains with different Crb1 mutations were generat-
ed (Table 1).
Clinical Evaluation and Electroretinography
Eyes of all mice used in the characterization studies and linkage
crosses were dilated with 1% atropine ophthalmic drops
(Bausch and Lomb Pharmaceuticals, Inc., Tampa, FL, USA) and
were evaluated by indirect ophthalmoscopy with a 78-diopter
(D) lens. Fundus photographs were taken with a small animal
fundus camera (Kowa American Corp., Torrance, CA, USA)
using a Volk superfield lens held 2 inches from the eye, as
previously described15 or with an in vivo bright field retinal
imaging microscope equipped with image-guided OCT capa-
bilities (Micron III; Phoenix Laboratories, Inc., Pleasanton, CA,
USA).
For electroretinographic evaluation of mutants, following
an overnight dark adaptation, mice were anesthetized with an
intraperitoneal injection of xylazine (80 mg/kg) and ketamine
(16 mg/kg) in normal saline. Additional anesthetic was given, if
akinesia was inadequate. The equipment and protocol used
here have been previously described.16 Briefly, dark-adapted,
rod-mediated ERGs were recorded with the responses to short-
wavelength flashes over 4.0-log units to the maximum intensity
by a photopic stimulator. Cone-mediated ERGs were recorded
with white flashes after 10 minutes of complete light
adaptation. The signals were sampled at 0.8-ms intervals and
averaged.
Histologic Analysis
Mice were asphyxiated by carbon dioxide inhalation, and
enucleated eyes were fixed overnight in cold methanol/acetic
acid solution (3:1, vol/vol). The paraffin-embedded eyes were
cut into 6-lm sections, stained with hematoxylin and eosin
(H&E), and examined by light microscopy.
Gene Mapping and Sequencing
To determine the chromosomal location of the rnv3 mutation,
we mated JR5558 mice to DBA/2J mice. The F1 mice, which
did not exhibit retinal abnormalities, were backcrossed to
JR5558 mice to produce N2 mice. Tail DNA was isolated as
previously reported.17 A genome-wide scan of pooled DNA
from 12 affected and 12 unaffected mice was carried out using
48 microsatellite markers.18 The fundus depigmentation
phenotype cosegregated with markers on chromosome 1.
Subsequently, DNAs of 120 N2 offspring were genotyped using
microsatellite markers to develop a fine structure map of the
chromosome 1 region. Microsatellite markers D1Mit387,
D1Mit103, D1Mit196 were used to genotype individual DNA
samples.
The Jak3m1J mutation was discovered during the course of
generating the linkage cross for rnv3 mapping. Normally, all
JR5558 parental mice were very sick or dying when they
reached ~6 months of age due to pneumocysitis, but
interestingly, all F1 parental mice appeared healthy and normal.
Necropsies of JR5558 mutants revealed small thymi and
spleens relative to wild-type, control B6 mice or F1 parental
mice. To determine the chromosomal location of the mutation
causing the tiny thymus and small spleen in JR5558, we mated
JR5558 mice to DBA/2J mice. The F1 mice were backcrossed
to JR5558 mice to produce N2 mice. A genome-wide scan of
pooled DNA from 12 affected (tiny thymus and small spleen)
and 12 unaffected mice was carried out using 48 microsatellite
markers. The tiny thymus and small spleen phenotype
cosegregated with markers on chromosome 8. Subsequently,
DNAs of 48 N2 offspring were genotyped using microsatellite
markers D8Mit4 and D8Mit132 to narrow the chromosome 8
region harboring the mutant gene.
The causative mutations for the fundus depigmentation and
for the reduced thymus and spleen phenotypes were
discovered by comparing the whole exome sequences from a
homozygous JR5558 mutants and control.19 Total RNA was
isolated from retinas of newborn mice by TRIZOL LS Reagent
(Invitrogen Life Technologies, Carlsbad, CA, USA) and a
preamplification system (SuperScript; Invitrogen Life Technol-
ogies) was used to make first strand cDNA. To confirm the
sequence changes in the mutant lines, the tail DNA or retinal
cDNA was used to amplify DNA fragments by PCR. The PCR
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products were purified from agarose gels using a commercial
kit (Qiagen, Inc., Valencia, CA, USA) and sequenced (DNA
Sequencing Facility, The Jackson Laboratory). Primers used in
the study are shown in Table 2.
TALEN-ODR Mediated Correction
The Crb1rd8 allele consists of a 1 base pair (bp) deletion
causing a frame shift and protein truncation20 and its TALEN-
mediated repair has been described previously.21 In brief,
fertilized oocytes isolated from strain JR5558 were coinjected
with TALEN mRNAs and single stranded oligonucleotides
(ssODN). The TALENs were designed to bind the following
s e q u e n c e s ( 5 0- T G A AG AC AG C TAC AG T T C a n d 5 0-
TCTCGGGATGGTCAGGGA). The intervening sequence (50-
TTATGGTGTGCCTGTC) contained the Crb1rd8 mutation and
is the site of TALEN-induced DNA cleavage. Oligonucleotide-
directed repair was facilitated by the presence of the 200-nt
ssODN (5 0-TTCTACAAATATGGTACTTACTGGCTGTTTGCCAT
CAAATGCCTGCCACTCCAGCCCCTGTTTGCATGGAGGAAACT
GTGAAGACAGTTACAGCAGTTATCGGTGTGCCTGTCTGTCG
GGATGGTCAGGGACACACTGTGAAATCAACATTGATGAGTGC
TTTTCTAGCCCCTGTATCCATGGCAACTGCTCTGATGGAG).
The corrected sequence encodes wild-type (WT) CRB1 and
matches the WT Crb1 nucleotide sequence with five additional
synonymous nucleotide alterations to assist in distinguishing
the WT versus corrected allele (Table 3). The resulting zygotes
were transferred and carried to term in pseudopregnant
females. A founder carrying the corrected allele was identified
by PCR screening (see below) and used to establish the strain.
Genotyping Protocols
Genomic DNA for genotyping mice was prepared from tail tips
by the rapid, hot sodium hydroxide and Tris (HotSHOT)
procedure.17 For PCR amplification, ~25 ng DNA was used in a
10-lL volume containing 50 mM KCl, 10 mM Tris–Cl, pH 8.3,
2.5 mM MgCl2, 0.2 mM oligonucleotides, 200 lM dNTP, and
0.02 U AmpliTaq DNA polymerase. The reactions were initially
denatured for 3 minutes at 948C, then subjected to 40 cycles of
15 seconds at 948C, 1-minute at 518C, 1-minute at 728C, and
then a final 7-minute extension at 728C. PCR products were
separated by electrophoresis on 3% MetaPhor (FMC, Rockland,
ME, USA) agarose gels and visualized under UV light after
staining with ethidium bromide.
Allele-specific PCR was used to detect the Crb1rd8
mutation.20 The Jak3m1J mutation resulted in a loss of a BsrFI
site that enabled us to genotype the Jak3m1J mutation with a
polymerase chain reaction and restriction fragment length
polymorphism (PCR-RFLP) assay. A 166-bp DNA fragment was
amplified from mutant and wild-type control DNA using the
following pair of primers (F¼50-TTCAGGAGCTCATGCAGCTG,
r ¼ 5 0-TCCTGCCTGAGGTCACACAG). BsrFI digestion was
performed by adding, 1 lL of 310 buffer (NE buffer 4) and
0.2 lL of BsrFI (01938, NEB Enzyme; New England Biolabs,
Ipswich, MA, USA) to 8.8 lL of each Jak3 amplified PCR
solution. After the BsrFI digestion, a single 166-bp band was
expected for mice homozygous for the Jak3m1J mutation,
whereas two bands of 123 bp and 43 bp were expected in
wild-type controls, and all three bands were expected in mice
heterozygous for the Jak3m1J mutation. The genotyping
protocol for the Crb1rd8 corrected allele (Crb1rd8þem1Boc)
was performed by a multiplex PCR amplification protocol.21
The five new Crb1 alleles generated from the TALENs rescue
experiment were genotyped by PCR with one pair of primers
(F ¼ 50-TGGTACTTACTGGCTGTTTGC, r ¼ 50-AATGTTGATTT
CACAGTGTGTCC). All mice heterozygous for the new Crb1
alleles showed one unique amplification product and an
invariant band of 140 bp, representing the wild-type PCR
fragment. For homozygous Crb1em2Boc mutants, a 123 bp band
was observed. Crb1em3Boc mutants showed a unique 115 bp
band. Crb1em4Boc homozygous mice have a 135 bp band and
Crb1em5Boc mice, a 137-bp band. To easily distinguish the
mutant band, we used the BanI restriction enzyme (01938,
New England Biolabs) to digest the PCR products. Only the
Crb1em5Boc DNA could be cut into 90- and 47-bp fragments.
Crb1em7Boc mice have a 95-bp band. The Crb1em6Boc mutation
was genotyped using the following primers (F ¼ 50-TGGTACT
TACTGGCTGTTTGC, R ¼ 50-CACAGACTGAGCTCCGAGTG).
Using these primers, one 104-bp band is amplified from
Crb1em6Boc homozygous mice while heterozygous mice also
have an additional 389-bp band.
RESULTS
Retinal Vascularization (RNV) in B6.Cg-
Crb1rd8Jak3m1J/Boc (JR#005558, JR5558, or rnv2)
Areas of retinal depigmentation without fluorescein leakage
were observed in JR5558 mice around 18 days of age (Fig. 1).
TABLE 1. JR5558-Rnv3 Related Strains Including Mice Generated by TALEN-Mediated NHEJ
Strains Stock No. Mutations Phenotypes*
B6.Cg-Crb1rd8Jak3m1J/Boc 005558 Crb1rd8 þ Jak3m1J RNV and tiny T
B6.Cg-Crb1rd8Jak3þ/Boc 031586 Crb1rd8 only Mild RNV and normal T
B6.Cg-Crb1þJak3m1J/Boc 031587 Jak3m1J only No RNV and tiny T
B6.Cg-Crb1rd8þem1BocJak3m1J/Boc 031589 Crb1rd8þem1Boc þJak3m1J No RNV and tiny T
B6.Cg-Crb1em2BocJak3m1J/Boc 031592 Crb1em2Boc þ Jak3m1J RNV and tiny T
B6.Cg-Crb1em3BocJak3m1J/Boc 031593 Crb1em3Boc þ Jak3m1J RNV and tiny T
B6.Cg-Crb1em4BocJak3m1J/Boc 031594 Crb1em4Boc þ Jak3m1J RNV and tiny T
B6.Cg-Crb1em5BocJak3m1J/Boc 031595 Crb1em5Boc þ Jak3m1J RNV and tiny T
B6.Cg-Crb1em6BocJak3m1J/Boc 031596 Crb1em6Boc þ Jak3m1J Mild RNV and tiny T
B6.Cg-Crb1em7BocJak3m1J/Boc 031597 Crb1em7Boc þ Jak3m1J Mild RNV and tiny T
Crb1rd8, a single base pair (bp) deletion (del) at nucleotide (nt) 3481 in Crb1 (crumbs family member 1) gene; Jak3m1J, a G to A transition at
nt3242 in Jak3 (Janus kinase 3) gene; Boc, Bo chang; Crb1rd8þem1Boc, endonuclease-mediated (em) revertant 1; Crb1em2Boc, 17-bp del (nt 3481–
3497); Crb1em3Boc, 25-bp del (nt 3467–3489); Crb1em4Boc, 5-bp del (nt 3481–3489); Crb1em5Boc, 3-bp del (nt 3483–3487); Crb1em6Boc, 285-bp del
(nt 3475–3747 þ 13-bp intron); Crb1em7Boc, 45-bp del (nt 3443–3497); T, thymus.
* The number of mice screened for RNV phenotype was 50 or more for each line and the number of mice screened for T phenotype was about
10 mice for each line.
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At 25 days of age, the number of depigmented spots increased,
and some of the depigmented areas corresponded to areas of
fluorescein leakage (Fig. 1). The retinal depigmented spots as
well as areas of fluorescein leakage increased in number and
size with age, with the maximal number of lesions reaching
about 20 per eye at about 1 month of age (Fig. 1). Around 2
months of age, some individual retinal depigmented spots
appeared to merge, generating larger areas of depigmentation
(Fig. 2). The number of areas demonstrating fluorescein
leakage decreased with age.
H&E–stained retinal sections of JR5558 mutants showed a
subretinal vascularization with a disturbance of the outer retina
TABLE 2. Primers Used for Sequencing and Genotyping
Primer Primer Sequence (50  30) Used For
Crb1-c1F AACAGGGATAGCTTCAGCAG Crb1 CDNA sequencing
Crb1-c1R CTACCTGTGCAGTCACAGTG Covers exon 1–4
Crb1-c2F CTGTGAACTCAGCGTTAATG Crb1 CDNA sequencing
Crb1-c2R GCACCTTTAACTGATTCCAG Covers exon 3–6
Crb1-c3F TCCTCATCCGAGGCAACAAG Crb1 CDNA sequencing
Crb1-c3R ATCTGACATCTTGAACACAG Covers exon 6–7
Crb1-c4F GTTCCTACATGGACAATTCG Crb1 CDNA sequencing
Crb1-c4R TTACCAGGGAAACCATGTAG Covers exon 7–9
Crb1-c5F ACCAATCTGTTGACAATCCG Crb1 CDNA sequencing
Crb1-c5R CTTCTCTGTCCTGAGAAGAG Covers exon 9–2
Crb1-mF1 GTGAAGAAGACAGCTACAGTTCTGATC Crb1rd8 genotyping
Crb1-mF2 GCCCCTGTTTGCATGGAGGAAACTTGG AAGACAGCTACAGTTCTTCTG mF1 þ mR ¼ 223 bp (WT)
mF2 þ mR ¼ 248 bp
Crb1-mR GCCCCATTTGCACACTGAT
Jak3-mF TTCAGGAGCTCATGCAGCTG Jak3m1J genotyping
Jak3-mR TCCTGCCTGAGGTCACACAG
#1303 GGGAAAGCTTCCCAGACTGACAAT Crb1rd8þem1Boc genotyping
#1353 CGACCAGACACCCTTTGTGATAAG 1303 plus 1353 ¼ 659 bp
#1368 CAGACAGGCACACCGATAACTG 1368 plus 1353 ¼ 330 bp
Crb1-tmF1 TGGTACTTACTGGCTGTTTGC Crb1em2Boc-em5Boc genotyping
Crb1-tmR1 AATGTTGATTTCACAGTGTGTCC and Crb1em7Boc genotyping
Crb1-tmF2 TGGTACTTACTGGCTGTTTGC Crb1em6Boc genotyping
Crb1-tmR2 CACAGACTGAGCTCCGAGTG
TABLE 3. The Sequences and Variations in Crb1 Gene and CRB1 Protein in JR5558 and Related Strains
bp, base pair; FS, frameshift; ET, early termination; LT, late termination.
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at 3 weeks of age (Fig. 3A). At 2 and 8 months (Figs. 3B, 3C,
respectively) of age, aberrant vessels span the region from the
RPE to the inner nuclear layer (INL; Fig. 3D). Photoreceptor
cell degeneration was observed where the ectopic vasculature
disrupts the retinal structure (Figs. 3B, 3C).
Electroretinograms of homozygous JR5558 mice showed a
slight decline in both scotopic and photopic responses to
visual stimuli at 8 weeks of age (Fig. 4). By 8 months of age,
mutants showed a much-reduced rod and cone ERG response
compared to that of C57BL/6J wild-type controls (Fig. 4).
The Crb1rd8 Mutation Is Associated With the
Aberrant Vascular Phenotype in Homozygous rnv3
Mutants
Genetic analysis indicated that the abnormal retinal vascular-
ization in homozygous rnv3 mice was inherited as a single
autosomal recessive mutation and that the rnv3 mutation
mapped to mouse Chr 1 between microsatellite markers
D1Mit103 and D1Mit196 (Fig. 5A). A genetic map of Chr 1
that encompasses the rnv3 locus with closely associated
markers, possible candidate genes, as well as the homologous
region in humans is shown in Figure 5B.
A whole mouse exome capture library prepared from DNA
from a homozygous rnv3 mouse was sequenced. The only
sequence change with a high mismatch ratio found within the
critical interval of the disease locus was a single nucleotide
deletion in exon 9 of the Crb1 gene, a previously reported
causative mutation for retinal degeneration 8 (rd8).20 This
nucleotide change is predicted to create a frameshift and
premature stop codon in the Crb1 transcript in rnv3 mice (Fig.
5C). Although not within the critical region of rnv3, genetic
variations in Vldlr and Ap1g1, genes previously associated with
retinal vascular abnormalities were also examined to exclude
their potential role in the rnv3 phenotype. Although we
cannot exclude noncoding regulatory changes, there was no
coding region variation found in either gene in rnv3 mutants.
A Second Mutation, in the Jak3 Gene, Is Identified
in JR5558 Mutants
Genetic analysis indicated that the small thymus and spleen
phenotype observed in homozygous JR5558 mice, named
mutation 1 Jackson (m1J), was inherited as a single autosomal
recessive mutation. The m1J mutation was mapped to mouse
Chr 8, closely linked to microsatellite markers D8Mit132 and
D8Mit4 (Fig. 5D). The genetic map of Chr 8 encompassing the
m1J locus, the closest markers, possible candidate genes, as
well as the homologous region in humans is depicted in Figure
5E.
A whole mouse exome capture library was prepared from
DNA from a JR5558 mouse and subjected to high-throughput
sequencing. Within the critical region in which the disease
locus resided, two sequence changes in the Jak3 gene with
high mismatch ratios were observed. The first nucleotide
FIGURE 1. Representive images of the clinical retinal phenotype of B6.Cg-Crb1rd8Jak3m1J/Boc (stock No. 005558) mice from 18 to 35 days of age
using optical coherence tomography and fluorescein angiography. The green lines are the plane in which the B-scan to the left of the fundus images
were taken in the same animal.
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substitution is unique and only present in JR5558 mice in exon
24 of Jak3 at position 3242. A G to A transition creates a
missense mutation, which changes codon 1081 from CGG to
CAG, which is predicted to alter the encoded amino acid from
arginine to glutamine in JR5558 mice (Fig. 5F). A second
nucleotide substitution was identified in exon 23 of Jak3 at
position 3095. An A to C transversion changes codon 1032
from AGC to CGC or an amino acid change from serine to
arginine. This nucleotide substitution was detected by
Nucleotide BLAST (https://blast.ncbi.nlm.nih.gov/, available
in the public domain) in 129/J strain (U70201), Mus caroli
(XM_021169344.1) and Mus musculus (BC131646, BC131647,
BC105577, L32995, and L40172-BALB/c, L33768). By checking
the sequence variations from Mouse Genome Project (http://
www.sanger.ac.uk/science/data/mouse-genomes-project, pro-
vided in the public domain by Wellcome Sanger Institute,
Cambridgeshire, UK), this nucleotide substitution was present
in 27 strains (129P2/OlaHsd, 129S1/SvImJ (Stock No: 002448),
129S5SvEvBrd, AKR/J (Stock No: 000648), BALB/cJ (Stock No:
000651), BUB/BnJ (Stock No: 000653), C3H/HeH, C3H/HeJ
(Stock No: 000659), CAST/EiJ (Stock No: 000928), CBA/J
(Stock No: 000656), DBA/1J (Stock No: 000670), DBA/2J
(Stock No: 000671), FVB/NJ (Stock No: 001800), I/LnJ (Stock
No: 000674), KK/HiJ (Stock No: 002106), LEWES/EiJ (Stock
No: 002798), LP/J (Stock No: 000676), MOLF/EiJ (Stock No:
000550), NZB/B1NJ (Stock No: 000684), NZO/HlLtJ (Stock No:
002105), NZW/LacJ (Stock No: 001058), RF/J (Stock No:
000682), SEA/GnJ (Stock No: 000644), SPRET/EiJ (Stock No:
001146), ST/bJ (Stock No: 000688), WSB/EiJ (Stock No:
001145) and ZALENDE/EiJ (Stock No: 001392) , but not in
the 10 strains (A/J (Stock No: 000646), BTBR (Stock No:
002282), C57BL/10J (Stock No: 000665), C57BL/6J (Stock No:
000664), C57BL/6NJ (Stock No: 005304), C57BR/cdJ (Stock
No: 000667), C57L/J (Stock No: 000668), C58/J (Stock No:
000669), NOD/ShiLtJ (Stock No: 001976) and PWK/PhJ (Stock
No: 003715).
To test if the Jak3m1J mutation contributed to the rnv3
phenotype, rnv3 mice were mated to C57BL/6J to produce
F1 mice. A total of 35 intercrossed (F2) mice were
genotyped for the Crb1rd8 and Jak3m1J mutations. Mice
homozygous for Crb1rd8 but wild-type for Jak3m1J were
selected to develop a new strain, B6.Cg-Crb1rd8Jak3þ/Boc
(stock #: 031586), which had a mild rnv3 phenotype, and
normal sized thymus and spleen (Fig. 6). The mice
homozygous for the Jak3m1J mutation, but wild-type for
Crb1rd8 were selected to develop another strain, B6.Cg-
Crb1þJak3m1J/Boc (stock#: 031587). This strain had a
normal retina, but small thymus and spleen (Fig. 6). Taken
together, these results suggest that Jak3m1J may have a
modifying effect, enhancing rnv3 disease severity, but that it
in itself does not cause a retinal phenotype.
FIGURE 2. Representive images of the clinical retinal phenotype of B6.Cg-Crb1rd8Jak3m1J/Boc mice from 2 to 9 months of age using optical
coherence tomography and fluorescein angiography. The green lines are the plane in which the B-scan to the left of the fundus images were taken in
the same animal.
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Abnormal Retinal Vascular Phenotype Ameliorated
in Crb1rd8 TALEN-Mediated ODR Strain
Although occasional angiogenic events were noted in Crb1rd8
mice,22 the significant ectopic retinal vascularization observed
in rnv3 mutants was not. Therefore, a rescue experiment was
conducted in which a corrected allele of Crb1 was introduced
by a TALEN-mediated oligonucleotide homology directed
repair (ODR) approach to confirm that Crb1rd8 contributed
to the phenotype. We generated 42 founder mice [1 to 25
(female), 26 to 42 (male)]. PCR followed by sequencing
revealed that 28 mice harbored a nonhomologous end-joining
(NHEJ) indel and/or presence of a ODR-corrected allele, and 14
did not. The overall NHEJ efficiency of TALEN in this
experiment was 76%. One male mouse (#26) appeared to
carry the corrected allele, one female (#24) carried a large
deletion and the remaining 26 founders were mosaic. Male #26
was mated to JR5558 to produce N1 mice. From a total of 23
N1 mice (13 female and 10 male), there were 2 female mice
carrying the corrected Crb1 allele (named Crb1rd8þem1Boc)
(Fig. 7). From these two female mice, we have developed a
new strain named B6.Cg-Crb1rd8þem1BocJak3m1J/Boc (Tables 1,
3). The TALEN-mediated ODR used directly in the rnv3/rnv3
genetic background was able to ameliorate the retinal vascular
lesions. This suggests that the Crb1rd8 mutation is necessary
for the development of the abnormal vascular phenotype in
rnv3 mutants.
Generation of Novel Nonhomologous End-Joining
Indel Models Associated With the Crb1 Locus
To determine if there were allelic effects of the different Crb1
variants obtained through the aberrant NHEJ events (i.e., more
extensive deletions, we established 6 additional lines; Tables 1,
3). Initially, we mated two female mosaic founders (#10 and
#20) to male JR5558 to produce a total of 14 N1 mice. We
established four strains from this outcross bearing different
deletions in the Crb1 gene from these N1 progeny. The
Crb1em2Boc strain bears a 17-bp deletion in exon 9, which
creates a frameshift and is predicted to result in a 7-amino acid
(aa) substitution and early termination. The Crb1em3Boc strain
has a 25-bp deletion in exon 9, which creates a frameshift and
likely results in a 44-aa substitution and early termination. The
Crb1em4Boc strain has a 5-bp deletion in exon 9, which creates
a frameshift and is likely to result in an 11-aa substitution and
early termination. These three Crb1 variants, which are
predicted to be null mutants, developed an abnormal retinal
vascular phenotype that was similar to that observed in
homozygous rnv3 mutant, which is also a null mutant. Unlike
the first three Crb1 variants, the fourth strain, Crb1em5Boc has a
discontiguous 3-bp deletion in exon 9, which is predicted to
lead to an in-frame substitution (1081 R to G) followed by a
deletion of a single amino acid (1082 C). Interestingly, the
retinal vascular phenotype appears to be even more severe
than observed in the rnv3 mutant, indicating an allelic effect
(Fig. 7).
FIGURE 3. Histological evaluation of B6.Cg-Crb1rd8Jak3m1J/Boc mice (A–C) demonstrating disease progression at (A) 3 weeks, (B) 2 months, (C) 8
months, and (D) an 8-month-old C57BL/6J control. Aberrant vascular lesions (arrows) are observed as early as 3 weeks, the earliest time examined,
and a thinning of the ONL, especially in those areas where the ectopic blood vessels were found. GC, ganglion cell layer; IPL, inner plexiform layer;
IS/OS, inner segment/outer segment; ONL, outer nuclear layer; OPL, outer plexiform layer; RPE, retinal pigment epithelium.
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Two additional strains in which large deletions that were
predicted to still generate partial CRB1 proteins were
established from a founder female mouse #24, which was
mated to JR5558 to produce a total of 16 N1 mice. Sequencing
of genomic DNA from Crb1em6Boc revealed a 285-bp deletion,
which included 272 bp of exon 9 and 13 bp from intron 9
(crossing an exon/intron boundary). By sequencing retinal
cDNA from homozygous Crb1em6Boc mice, we found an
additional 125 bp was skipped in exon 9, thus, 397 bp was
deleted in the 30 end of exon 9 from the transcript. This
mutation is predicted to cause a 132-aa deletion and frameshift
which results in a 157-aa substitution with 12 additional amino
acids due to a late termination. This mutant strain exhibits a
much reduced retinal neovascular phenotype (Fig. 8) com-
pared to the rnv3 mutant. Genomic sequencing of Crb1em7Boc
revealed a 45-bp deletion in exon 9, which leads to a
restoration of the reading frame. Sequencing of retinal cDNA
from Crb1em7Boc indicates a 15-aa deletion followed by a single
aa substitution. This mutation also has a mild retinal
neovascular phenotype (Fig. 8) compared to the rnv3 mutant.
Three of the six lines identified with nonhomologous end
joining (NHEJ) without ODR of Crb1 that caused frameshifts
and early termination of the gene all had a similar retinal
vascular phenotype as the parental rnv3/rnv3 line, suggesting
the absence of Crb1 unmasks the angiogenic effect in the rnv3
strain. Consistent with this interpretation, two lines with in-
frame deletions where partial CRB1 protein is anticipated, a
70% reduction in vascular lesions was observed. The in-frame
deletions occurred in the extracellular domain of the Crb1
gene. The one exception to the allelic effects observed is in the
Crb1em5Boc strain, which shows a severe retinal vascular
phenotype despite the prediction that a CRB1 protein would
be made. It should be noted, however, that initially—until
N1F5, this line exhibited a 70% reduction in retinal vascular-
ization as well, but with further inbreeding the phenotype
became significantly more severe than even that observed in
the rnv3 strain, suggesting that other factors in the genetic
background that modified the phenotype became fixed with
time.
DISCUSSION
Abnormal retinal vascularization, a pathologic condition in
many vision-threatening diseases, can lead to serious conse-
quences, including blindness.5-8,14 Development of reproduc-
ible and reliable animal models of RNV has advanced our
understanding of both the normal development and pathobi-
ology of aberrant retinal vascularization. In this study, we
describe robust, heritable mouse models of abnormal retinal
vascularization, one of which is caused by a nucleotide
deletion in the Crb1gene that was previously described as the
retinal degeneration 8 (rd8) mutation.22–24 The rd8 mutation
is common and presents in many mouse strains,22–24 but the
retinal phenotype differs substantially from that observed in
the rnv3 model. This model, rnv3, made available through
the JAX Eye Mutant Resource, was previously described by
two groups.7–8 The first report indicated that the ectopic
vascular vessels were choroidal in origin and infiltrated the
RPE and intraretinal space.7 The second group reported that
the model captured the early stages of retinal angiomatous
proliferation (RAP), with intraretinal vessels diving into the
subretinal space but not breaching the RPE.8 The rnv3
phenotype has been recently described in many publications
referred to as JR55587,14,25–27 or NRV28 but the molecular
basis for the disease was not reported. We mapped the rnv3
FIGURE 4. ERG responses of B6.Cg-Crb1rd8Jak3m1J/Boc and C57BL/6J at 8 weeks and 8 months of age. Scotopic responses were recorded after an
overnight dark-adaptation, while light-adapted responses were recorded with a background light of 1.46 log cd/m2 following a 10-minute exposure
of the same range of stimulus intensities (see ‘‘Methods’’). A reduction in scotopic ERG response is observed at 8 weeks in B6.Cg-Crb1rd8Jak3m1J/
Boc mutants compared to controls, and in 8 week old compared to 8-month-old B6.Cg-Crb1rd8Jak3m1J/Boc mutants. Both scotopic and photopic
responses were reduced in 8 month old mutants compared to 8-week-old mutants.
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phenotype to mouse Chr 1 in a region containing Crb1, Cfh
(component factor h) and Cfh-related genes 1 through 3. We
did not consider Crb1 as a reasonable candidate because of
the vast difference in the retinal phenotype observed in the
stock Crb1rd8 mouse model compared with rnv3 mutants.
Therefore, rnv3 retinal cDNA was screened for mutations
within Cfh, Cfhr1, Cfhr2, and Cfhr3; no coding sequence
variation was detected.
Whole genome sequencing of rnv3 DNA, revealed, howev-
er, that Crb1rd8 was the only coding sequence alteration in the
critical region. To confirm the Crb1rd8 was the causative
mutation for the rnv3 phenotype, we used a TALEN-mediated
oligonucleotide directed repair to correct the Crb1rd8 mutation
in the rnv3 model, as previously described for correction of
the Crb1rd8 mutation in B6/N mice.21 Unlike rnv3 (JR5558)
mice, which exhibits abnormal retinal vascularization, hetero-
zygous Crb1em1Boc/Crb1rd8 mice, bearing the corrected Crb1
allele, showed a normal retinal phenotype. This result verified
that the Crb1rd8 mutation was necessary for the aberrant
retinal vascularization to occur in the JR5558 genetic
background. The phenotypic difference between stock
Crb1rd8 and rnv3 is most likely due to genetic background
differences between the strains. That is, the genes that interact
with the Crb1rd8 gene to cause early onset abnormal retinal
vascularization in the rnv3 strain differ from those genes that
are present in the original stock Crb1rd8 strain that leads to a
retinal spotting phenotype.
However, in addition to genetic background effects,
extensive founder mosaicism in the Crb1 gene captured in
strains Crb1em2Boc, Crb1em3Boc, Crb1em4Boc, and Crb1em5Boc
were also able to cause the abnormal vascular phenotype in
the JR5558 background. Two additional mutations: Crb1em6Boc
and Crb1em7Boc, in which a mutant CRB1 protein may still
retain some function, lead to a mild retinal vascular phenotype
in the JR5558 genetic background. Further studies are needed
to confirm the basis for the allelic differences.
Crb1 encodes a mammalian homolog of Drosophila
crumbs, which is a membrane protein that establishes
apicobasal cell polarity and adhesion between cells. In the
mammalian eye, CRB1 is expressed in Mu¨ller glia cells (mouse)
or in Mu¨ller glia and photoreceptor cells (human),28,29 where it
contributes to the formation of adherens junctions that
constitute the external limiting membrane (ELM), which
provides structural cell-cell contact, diffusion barrier, and
mediates intracellular signal transduction needed for normal
development and tissue maintenance. The Crb1rd8 mutation in
mice is associated with retinal ELM fragmentation and outer
retinal dysplasia.20,21 A mutation in Crb1 in rat links aberrant
Mu¨ller glial cell function to retinal telangiectasia and progres-
sive retinal degeneration that is associated with early retinal
vascular leaky telangiectasia, and late intraretinal neovascular-
ization, neuronal alterations, and loss of retinal Mu¨ller glial
cells. These disease characteristics resemble pathologies
observed in human macular telangiectasia type 2 (MacTel
FIGURE 5. Genetic and molecular analysis of the rnv3 strain. (A) A total of 120 progeny from a rnv3/rnv3 X (rnv3/DBA/2J) F1 mice backcross were
genotyped. Linkage to several markers on mouse Chr 1 was observed. The columns of squares represent haplotypes (filled boxes, rnv3/rnv3 allele;
open boxes, rnv3/DBA/2J allele). The number of chromosomes associated with each haplotype is indicated below each column. (B) Genetic map of
Chr 1 in the rnv3 region showing the closest markers and the region of human homology. (C) Integrative genomics viewer (IGV) shows the deleted
base. (D) A total of 48 progeny from a m1J/m1J x (m1J/DBA/2J) F1 mice backcross were genotyped. Linkage to several markers on mouse Chr 8
was observed. The columns of squares represent haplotypes (filled boxes, m1J3/m1J allele; open boxes, m1J/DBA/2J allele). The number of
chromosomes associated with each haplotype is indicated below each column. (E) Genetic map of Chr 8 in the m1J region showing the closest
markers and the region of human homology. (F) IGV shows the base substitution.
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2).30 Over 150 CRB1 alleles31 have also been reported to cause
a multitude of human retinal diseases. CRB1 variants are
associated with retinal degenerative phenotypes ranging from
Leber congenital amaurosis 8 (MIM# 613835), characterized by
congenital or early-onset blindness, to retinitis pigmentosa
(RP12, MIM# 600105), a more slowly progressive disease.
CRB1 RP variants are often associated with unique disease
features, such as retinal telangiectasia with or without
exudative retinal detachment (Coat disease), a loss of RPE
pigmentation except near arterioles (preservation of para-
arteriolar RPE), pigment paravenous chorioretinal atrophy
(PPCRA, MIM# 172870), cone-rod dystrophy, nanophthalmos
with optic disc drusen, and macular dystrophy disease.
Although null mutations appear to be overrepresented in
LCA patients carrying CRB1 mutations,32 attempts to correlate
the CRB1 genotype with unique disease features have not been
successful; perhaps the range of disease phenotypes observed
is a consequence of interactions with additional genetic and/or
environmental factors.31,32
We discovered the rnv3 mutation on stock JR4454 (B6;129-
Crhr1tm1Klee/J, stock # 004454). By outcrossing rnv3 mutants
to C57BL/6J and intercrossing to select mice with the most
severe rnv3 phenotype for 5 generations (N5), we developed
the JR5558 strain without the Crhr1tm1Klee mutation. This
result indicates that the Crhr1 (corticotropin releasing
hormone receptor 1) mutation does not contribute to the
rnv3 phenotype. Genotyping archived DNA samples from
JR4454 for Crb1rd8 and Jak3m1J (DNA sample purchased from
Mouse DNA Resource at The Jackson Laboratory), showed that
this strain was found to be homozygous for the Crb1rd8
mutation, but heterozygous for the Jak3m1J mutation. The
discovery of the Jak3m1J mutation in JR5558 mice was
fortuitous, but whether the mutation contributes to the
abnormal retinal vascularization phenotype requires further
investigation. By outcrossing JR5558 mice with C57BL/6J, we
FIGURE 6. Representive clinical retinal images and representive thymus and spleen images as well as weights of the thymus and spleen in B6.Cg-
Crb1rd8Jak3þ/Boc (stock number: 031586) and B6.Cg-Crb1þJak3m1J/Boc (stock number: 031587) mice. The top panel shows the mild rnv3
phenotype in B6.Cg-Crb1rd8Jak3þ/Boc, that is not observed in B6.Cg-Crb1þJak3m1J/Boc mice at 1 month of age. The bottom panel shows the
normal size and weights of the spleen and thymus from B6.Cg-Crb1rd8Jak3þ/Boc (right-WT) mice, and much smaller spleen and thymus of B6.Cg-
Crb1þJak3m1J/Boc (left-mut) mice at 3 weeks of age. The spleen weight (white bar, mut [mutant] mice¼ 36.6 6 3.21 mg and gray bar, WT [wild-
type] mice¼ 81 6 5.61 mg; *****statistically significant at P < 0.000005) and thymus weight (white bar, mut mice¼ 10.6 6 2.7 mg and gray bar,
WT mice ¼ 87.2 6 11.95 mg; ****statistically significant at P < 0.0002) at 3 weeks of age.
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FIGURE 7. Representative fundus images of retinal phenotypes of strains generated by the TALEN-mediated ODR at 1 month of age.
FIGURE 8. Representative fundus images of retinal phenotypes of strains generated by the TALEN-mediated ODR at 1 month of age.
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separated the Jak3m1J mutation from Crb1rd8 and generated
two strains through selective intercrossing: B6.Cg-
Crb1rd8Jak3þ/Boc and B6.Cg-Crb1þJak3m1J/Boc. The strain
with only the Crb1rd8 mutation has a mild retinal neovascu-
larization phenotype, while the strain with only the Jak3m1J
mutation had a normal retina. These results indicate that the
Jak3m1J mutation itself does not cause retinal abnormalities,
but when combined with the disruption in the Crb1 gene leads
to an enhancement of the retinal vascular disease phenotype.
Further, when we were establishing the JR5558 strain, we
selected for mutants with the most severe rnv3 phenotype
mice to produce future generations without knowing the
genotype of the mating pairs. Using this genotype-blind
strategy, we find that the current JR5558 strain is homozygous
for both mutations of Crb1rd8 and Jak3m1J.
Janus kinase 3 (JAK3) is critical for the normal develop-
ment and function of the immune system. Signals relayed by
the JAK3 protein regulate the development and maturation of
certain types of white blood cells (lymphocytes) such as B, T,
and natural killer cells. These cells neutralize pathogens, such
as bacteria, viruses, and fungi, by recognizing antigens that
are non-self.33–39 JAK3-deficient severe combined immunode-
ficiency (SCID) is caused by mutations in the JAK3 gene and
its signaling pathways are essential for T lymphocyte
differentiation (IL-7/JAK3) and NK cell development (IL-15/
JAK3).40,41 These immune cell types, however, are generally
not found in the retina—but it is possible that they may signal
to other cells of the immune system, that may indirectly affect
retinal angiogenesis. It is of interest; therefore, that the
vascular lesions in rnv3 mutants are associated with F4/80þ
staining cells.25 Within the retina, the immune cells, microglia
and blood-derived macrophages (reported in experimentally
induced models) are F4/80þ.25 The role of JAK3 in these cell
types has not been studied. However, Jak3 expression is
found throughout the retina and has been shown to increase
in heritable and light-induced retinal degenerative condi-
tions.42,43 Taken together, it is conceivable that impaired JAK3
function might contribute to an enhanced pathology in rnv3
retinas. Correcting the Jak3m1J mutation using a similar
approach used for Crb1rd8 or rnv3, in this study, where the
genetic background could be preserved, and assessing for
angiogenic events would help to resolve this issue.
In summary, we have identified the disrupted gene, Crb1,
which is necessary for the posterior segment retinal vascular
phenotype found in rnv3/rnv3 mutants and verified causal-
ity by TALEN-mediated, oligonucleotide-directed repair res-
cue of the disease phenotype. Additionally, six novel
mutations in Crb1 were generated through NHEJ, and mice
bearing the alleles exhibited variable levels of retinal vascular
abnormalities. Further study of these models may provide a
greater understanding of how different Crb1 alleles result in
aberrant retinal vascular development. Finally, we have also
potentially identified an enhancer of the vascular phenotype,
Jak3mlJ, in rnv3 mice. Further investigation is necessary to
confirm its effects on Crb1rd8-mediated development of
ectopic retinal vessels, and to understand the mechanism
through which it might act to enhance the disease
phenotype.
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